Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options

Background: Hypovitaminosis D can cause immunological irregularities in the development of immune thrombocytopenia. Objectives: To identify the frequency of low levels of 25-hydroxyvitamin D in children with Immune thrombocytopenia (ITP), and to assess the effect of the disease phase and type of...

Full description

Saved in:
Bibliographic Details
Main Authors: Huda K. Abbas, Basil O. Saleh, Hassanain H. Ghali
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2024-12-01
Series:مجلة كلية الطب
Subjects:
Online Access:https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2401
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594706730582016
author Huda K. Abbas
Basil O. Saleh
Hassanain H. Ghali
author_facet Huda K. Abbas
Basil O. Saleh
Hassanain H. Ghali
author_sort Huda K. Abbas
collection DOAJ
description Background: Hypovitaminosis D can cause immunological irregularities in the development of immune thrombocytopenia. Objectives: To identify the frequency of low levels of 25-hydroxyvitamin D in children with Immune thrombocytopenia (ITP), and to assess the effect of the disease phase and type of treatment on vitamin D level. Methods: This case-control study was carried out on 88 children (63 had been diagnosed with immune thrombocytopenia and 25 healthy children as controls) during November 2023 and April 2024. The patients were sub-grouped according to global classification of vitamin D level into three groups: less than 10 ng/ml (n = 47), 10–20 ng/ml (n = 16), and 20-30 ng/ml (none of the patients or controls fell in this group). The cases were sub-classified according to their disease phase: Acute (n = 21), persistent (n = 24), and chronic (n = 18). The serum 25-hydroxyvitamin D level was measured using the enzyme-linked immunosorbent assay (ELISA) technique. Results: Around 75% of ITP children had a serum 25-hydroxyvitamin D level of less than 10 ng/ml. The mean (± SEM) values of the serum 25-hydroxyvitamin D of the ITP children of acute (9.5±1.84 ng/ml) and chronic (8.0±1.13 ng/ml) phases were lower than those of controls (10.0±1.32 ng/ml, p > 0.05), but not significantly so. The mean values of 25 hydroxyvitamin D of ITP children were lower than those of the controls, irrespective of the type of treatment. Conclusion: Vitamin D deficiency is prevalent among children with immune thrombocytopenia, particularly those in the chronic phase.  
format Article
id doaj-art-8fe8921451554266bb6aef87909ddc6f
institution Kabale University
issn 0041-9419
2410-8057
language English
publishDate 2024-12-01
publisher College of Medicine University of Baghdad
record_format Article
series مجلة كلية الطب
spelling doaj-art-8fe8921451554266bb6aef87909ddc6f2025-01-19T12:24:08ZengCollege of Medicine University of Baghdadمجلة كلية الطب0041-94192410-80572024-12-0166410.32007/jfacmedbaghdad.6642401Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy OptionsHuda K. Abbas0https://orcid.org/0009-0008-2791-0043Basil O. Saleh1https://orcid.org/0009-0001-0053-5422Hassanain H. Ghali2https://orcid.org/0000-0003-0860-1479Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad, Iraq.Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad, Iraq.Department of Pediatric, College of Medicine, University of Baghdad, Baghdad, Iraq. Background: Hypovitaminosis D can cause immunological irregularities in the development of immune thrombocytopenia. Objectives: To identify the frequency of low levels of 25-hydroxyvitamin D in children with Immune thrombocytopenia (ITP), and to assess the effect of the disease phase and type of treatment on vitamin D level. Methods: This case-control study was carried out on 88 children (63 had been diagnosed with immune thrombocytopenia and 25 healthy children as controls) during November 2023 and April 2024. The patients were sub-grouped according to global classification of vitamin D level into three groups: less than 10 ng/ml (n = 47), 10–20 ng/ml (n = 16), and 20-30 ng/ml (none of the patients or controls fell in this group). The cases were sub-classified according to their disease phase: Acute (n = 21), persistent (n = 24), and chronic (n = 18). The serum 25-hydroxyvitamin D level was measured using the enzyme-linked immunosorbent assay (ELISA) technique. Results: Around 75% of ITP children had a serum 25-hydroxyvitamin D level of less than 10 ng/ml. The mean (± SEM) values of the serum 25-hydroxyvitamin D of the ITP children of acute (9.5±1.84 ng/ml) and chronic (8.0±1.13 ng/ml) phases were lower than those of controls (10.0±1.32 ng/ml, p > 0.05), but not significantly so. The mean values of 25 hydroxyvitamin D of ITP children were lower than those of the controls, irrespective of the type of treatment. Conclusion: Vitamin D deficiency is prevalent among children with immune thrombocytopenia, particularly those in the chronic phase.   https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2401AutoimmuneImmune ThrombocytopenicPurpuraThrombocytopenic25-hydroxy vitamin D
spellingShingle Huda K. Abbas
Basil O. Saleh
Hassanain H. Ghali
Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
مجلة كلية الطب
Autoimmune
Immune Thrombocytopenic
Purpura
Thrombocytopenic
25-hydroxy vitamin D
title Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
title_full Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
title_fullStr Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
title_full_unstemmed Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
title_short Frequency of 25-Hydroxyvitamin D Deficiency in Pediatric Patients with Immune Thrombocytopenia: Disease Phase and Therapy Options
title_sort frequency of 25 hydroxyvitamin d deficiency in pediatric patients with immune thrombocytopenia disease phase and therapy options
topic Autoimmune
Immune Thrombocytopenic
Purpura
Thrombocytopenic
25-hydroxy vitamin D
url https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/2401
work_keys_str_mv AT hudakabbas frequencyof25hydroxyvitaminddeficiencyinpediatricpatientswithimmunethrombocytopeniadiseasephaseandtherapyoptions
AT basilosaleh frequencyof25hydroxyvitaminddeficiencyinpediatricpatientswithimmunethrombocytopeniadiseasephaseandtherapyoptions
AT hassanainhghali frequencyof25hydroxyvitaminddeficiencyinpediatricpatientswithimmunethrombocytopeniadiseasephaseandtherapyoptions